The trademark application NUVAXOVID was filed by Novavax, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on September 1, 2021, and it was registered by office on December 9, 2021 without any oppositions.
The application was filed in English (French was selected as the second language).
Appointment and Replacement of representative of the trademark registration was recorded on March 27, 2024.
Goods And Services
The mark was filed in class 5 with Vaccines for the treatment and prevention of Covid-19.
The mark was filed in class 42 with following description of goods:
Providing medical and scientific research information in the field of Covid-19 vaccines, and clinical trials and post-market trials related to Covid-19 vaccines
Consulting services in the field of research and development of Covid-19 vaccines